3,3-disubstituted indolines
CA 1301151 C · Owner: E.I. Du Pont De Nemours And Company · Inventors: Nickolson, Victor Johannes; Myers, Melvyn John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Title BP-6303-A, 3,3-DISUBSTITUTED INDOLINES Abstract of the Disclosure, Cognitive deficiencies and/or neurological function deficits and/or mood and/or mental disturbances are treated by the administration of 3,3-disubtituted indolines. The indolines have the formula: ( I ), wherein:, p is O or 1:, Z is O or S; R is Cl-C10 alkyl, C3-C8 cycloalkyl, 2-pyridyl 3-pyridyl, 4-pyridyl or, V, W, X, and Y independently are H halo. Cl-C3, alkyl, OR1, N02, CF3, CN or NR1R2; Rl and R2 independently are H or Cl-C3 alkyl; - ? and - ? independently are 6-membered heterocyclic aromatic rings containing at least one nitrogen atom as a part of the ring optionally substituted with one, substituent selected …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 19, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 19, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.